Australia markets closed

PYC Therapeutics Limited (PYC.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0730+0.0030 (+4.29%)
At close: 03:55PM AEST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2021
30/06/2020
30/06/2019
30/06/2018
Operating expenses
Research development
20,105
14,004
-
-
-
Selling general and administrative
8,164
6,176
5,671
1,828
1,163
Total operating expenses
29,662
21,833
9,745
7,102
9,768
Operating income or loss
-26,562
-21,833
-9,745
-7,102
-9,768
Interest expense
-
38.822
-
-
-
Total other income/expenses net
9,139
3,133
62.5
0.25
48.46
Income before tax
-17,371
-18,630
-9,475
-6,984
-9,605
Income tax expense
0
0
-2,396
-2,904
-2,171
Income from continuing operations
-17,371
-18,630
-7,080
-4,080
-7,434
Net income
-16,816
-17,768
-6,822
-4,080
-7,434
Net income available to common shareholders
-16,816
-17,768
-6,822
-4,080
-7,434
Basic EPS
-
-0.01
-0.00
-0.00
-0.00
Diluted EPS
-
-0.01
-0.00
-0.00
-0.00
Basic average shares
-
3,091,647
2,641,766
2,455,400
2,173,151
Diluted average shares
-
3,091,647
2,641,766
2,455,400
2,173,151
EBITDA
-
-17,969
-9,198
-6,972
-9,687